Emerging risks | Growth Opportunities | APAC Insurance

Tuesday, July 21, 2026

Industry M&A, Life, Life and Health, News, Regulatory, Strategy

Regulatory scrutiny, shareholder objections delay Woori’s Tongyang Life delisting plan — report

Regulatory scrutiny and minority shareholder opposition are raising questions over valuation and deal fairness.

By

Gloria Methri

June 30, 2026

•

3 min read

The Inaugural Recognising excellence in Asia's insurance industry Find out more → Entries close
28 August

Already a member? Sign in →

MEMBERS ONLY

Continue reading with a free account.

• Free daily briefing in your inbox each morning

• 14 day trial to (Re)in Asia's premium intelligence

• No credit card required

The Inaugural Recognising excellence in Asia's insurance industry Find out more → Entries close
28 August

Read next